Related Experiment Videos
Positron emission tomography of soft tissue sarcomas
Noobar Israel-Mardirosian1, Lee P Adler
1Department of Diagnostic Imaging, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA.
Current Opinion in Oncology
|July 23, 2003
Summary
Positron emission tomography (PET) enhances soft tissue sarcoma management by assessing tumor biology. This functional imaging complements biopsy, aiding in diagnosis, staging, and prognosis.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Soft tissue sarcomas require accurate diagnosis and management.
- Tumor biopsy is essential, but functional imaging is increasingly valuable.
- Positron emission tomography (PET) offers insights into cellular metabolism.
Purpose of the Study:
- To highlight the importance of PET in managing soft tissue sarcoma patients.
- To demonstrate PET's role beyond differentiating benign and malignant lesions.
Main Methods:
- Review of current literature on PET in soft tissue sarcoma.
- Utilizing fluorodeoxyglucose (18FDG) as a primary radiotracer.
- Analysis of PET's ability to assess tumor characteristics.
Main Results:
- PET detects intralesional morphologic variations in soft tissue sarcomas.
- PET can predict tumor grade and aid in staging and restaging.
- PET provides valuable prognostic information.
Conclusions:
- PET is a valuable tool for understanding soft tissue sarcoma biology.
- PET complements, rather than replaces, traditional tissue biopsy.
- PET improves patient management through comprehensive tumor assessment.